UBS Group’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Buy |
22,592
+10,676
| +90% | +$11.6K | ﹤0.01% | 6997 |
|
|
2025
Q1 | $14.9K | Buy |
11,916
+10,042
| +536% | +$12.6K | ﹤0.01% | 7098 |
|
|
2024
Q4 | $2.94K | Sell |
1,874
-6,480
| -78% | -$10.2K | ﹤0.01% | 7714 |
|
|
2024
Q3 | $16K | Sell |
8,354
-19,221
| -70% | -$36.7K | ﹤0.01% | 6284 |
|
|
2024
Q2 | $54K | Buy |
27,575
+27,566
| +306,289% | +$54K | ﹤0.01% | 5490 |
|
|
2024
Q1 | $21 | Sell |
9
-4
| -31% | -$9 | ﹤0.01% | 7858 |
|
|
2023
Q4 | $29 | Buy |
13
+4
| +44% | +$9 | ﹤0.01% | 7831 |
|
|
2023
Q3 | $19 | Hold |
9
| – | – | ﹤0.01% | 7980 |
|
|
2023
Q2 | $25 | Sell |
9
-1,679
| -99% | -$4.66K | ﹤0.01% | 7585 |
|
|
2023
Q1 | $4.91K | Buy |
1,688
+1,679
| +18,656% | +$4.89K | ﹤0.01% | 7023 |
|
|
2022
Q4 | $27 | Hold |
9
| – | – | ﹤0.01% | 9332 |
|
|
2022
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 9573 |
|
|
2022
Q2 | $0 | Sell |
9
-5,823
| -100% | – | ﹤0.01% | 9602 |
|
|
2022
Q1 | $13K | Buy |
5,832
+2,171
| +59% | +$4.84K | ﹤0.01% | 7017 |
|
|
2021
Q4 | $9K | Buy |
3,661
+260
| +8% | +$639 | ﹤0.01% | 7796 |
|
|
2021
Q3 | $11K | Buy |
+3,401
| New | +$11K | ﹤0.01% | 6756 |
|